pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
ROCHE · news · pharmadog
← back to ROCHE
News mentioning ROCHE
262
stories
Jul 2, 26
Roche KRAS drug succeeds in head-to-head lung cancer study
biopharma dive
Jul 2, 26
STAT+: Roche drug sets new standard for KRAS-driven lung cancer
stat
Jul 2, 26
Roche’s KRAS G12C inhibitor beats rivals in head-to-head Phase 3 study
endpoints
Jun 30, 26
These biotechs just landed big fundraising hauls. Here’s what they pitched to investors.
biopharma dive
Jun 12, 26
STAT+: Pharmalittle: We’re reading about a discontinued cancer drug, a Novo security breach, and more
stat
Jun 11, 26
STAT+: Pharmalittle: We’re reading about employer coverage of obesity drugs, another Sanofi setback, and more
stat
Jun 11, 26
Exclusive: Genentech closes infectious disease unit in wave of research layoffs
endpoints
Jun 10, 26
STAT+: Pharmalittle: We’re reading about U.S. pressure on European drug prices, longer shortages, and more
stat
Jun 9, 26
STAT+: The shortage of many medicines in the U.S. remains a ‘systemic’ problem, a new analysis finds
stat
Jun 9, 26
STAT+: Pharmalittle: We’re reading about a $10.6 billion GSK deal, an AstraZeneca obesity pill, and more
stat
Jun 8, 26
Health workers at the epicenter of Congo’s Ebola outbreak labor with little pay or rest
stat
Jun 8, 26
#ADA26: AstraZeneca's GLP-1 pill cuts weight by 10.5% after six months
endpoints
Jun 8, 26
STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials
stat
Jun 8, 26
Roche stakes $700M on Nurix’s protein-degrading drug
biopharma dive
Jun 8, 26
ADA ‘26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ option
biopharma dive
Jun 8, 26
STAT+: Novo underwhelmed by drug it once fought Pfizer for
stat
Jun 8, 26
STAT+: Pharmalittle: We’re reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and more
stat
Jun 8, 26
Nurix to work with Roche on BTK degrader in pact worth up to $2.3B
endpoints
Jun 6, 26
#ADA26: Roche to start Phase 2 petrelintide, enicepatide combo trial this year
endpoints
Jun 5, 26
#ADA26: Roche's incretin shot works in mid-stage trial in type 1 diabetes
endpoints
Jun 5, 26
STAT+: Up and down the ladder: The latest comings and goings
stat
Jun 5, 26
STAT+: Pharmalittle: We’re reading about Roche accusing U.S. of ‘blackmail,’ a ruling on skinny labels, and more
stat
Jun 3, 26
Lilly, Ascidian link up in RNA exon editing pact
biopharma dive
Jun 2, 26
#ASCO26: Roche details narrow failure of breast cancer pill trial
endpoints
May 29, 26
Pfizer, Innovent strike $10B cancer drug deal
biopharma dive
May 18, 26
FDA approves AstraZeneca’s new kind of hypertension drug
biopharma dive
May 15, 26
Biotech leaders campaign for Pazdur; Takeda to lay off 4,500 workers
biopharma dive
May 14, 26
BeOne’s next-gen BCL2 inhibitor wins FDA approval, taking aim at Venclexta
endpoints
May 12, 26
STAT+: Hims’ sales miss as telehealth competition grows
stat
May 8, 26
Post–T-DXd Sacituzumab Govitecan Plus Trastuzumab Yields Low ORR in HER2+ Metastatic Breast Cancer
onclive
← prev
page 8 of 9
next →
